Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G, Zheng J, Knudsen BS, Kardinal C, Müller KB, Voss J, Shishido T, Cowburn D, Cheng G, Wang B, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zamborelli TJ, Adermann K, Hanafusa H, Feller SM.
Posern G, et al. Among authors: kardinal c.
Oncogene. 1998 Apr 16;16(15):1903-12. doi: 10.1038/sj.onc.1201714.
Oncogene. 1998.
PMID: 9591773